Tissue Dynamics

Tissue Dynamics is a biotechnology company that is committed to fundamentally transforming drug and cosmetic development by advancing next-generation organ on chip (OOC) tools for the pharmaceutical, nutraceutical, and cosmetic industries. The company is focused on disrupting the drug development landscape, by dramatically increasing clinical success rates using human-relevant models and sensor-driven discovery. Its bionic OOC platform provides critical tools for faster, safer, and more effective drug development while substantially cutting research and development costs. The novel design of Tissue Dynamics sensor-integrated organ tissues presents a quantum leap over existing OOC technologies. The platforms 3D microphysiological models emulate critical aspects of human physiology while endowing the user with a real-time monitoring system that analyzes the data using a smart algorithm, enabling a revolutionary new understanding of the tissue dynamics.

Tissue Dynamics has raised $3.26M in total funding across 2 rounds. The company is currently at the Pre-Funding stage.

Tissue Dynamics was founded in 2017 by Yaakov Nahmias (Founder & CSO).

Tissue Dynamics operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Artificial Intelligence, Simulation & Imaging, Sensing. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals, Biotechnology.

Tissue Dynamics is based in Givat Ram, Jerusalem, Israel, Jerusalem District.